Preprint Case Report Version 1 This version is not peer-reviewed

A Case Of Successful Dupilumab Treatment In Allergic Rhinitis And Atopic Dermatitis In Patient With Multiple Food Allergies, Pollen And Perennial Sensitization

Version 1 : Received: 31 October 2024 / Approved: 31 October 2024 / Online: 1 November 2024 (12:44:36 CET)

How to cite: Sculco, E.; Garzi, G. A Case Of Successful Dupilumab Treatment In Allergic Rhinitis And Atopic Dermatitis In Patient With Multiple Food Allergies, Pollen And Perennial Sensitization. Preprints 2024, 2024110012. https://doi.org/10.20944/preprints202411.0012.v1 Sculco, E.; Garzi, G. A Case Of Successful Dupilumab Treatment In Allergic Rhinitis And Atopic Dermatitis In Patient With Multiple Food Allergies, Pollen And Perennial Sensitization. Preprints 2024, 2024110012. https://doi.org/10.20944/preprints202411.0012.v1

Abstract

Dupilumab is an interleukin 4 (IL-4) receptor α-antagonist that inhibits IL-4 and IL-13 signaling through blockade of the shared IL-4αR subunit. Blockade of IL-4/13 is effective in reducing Th2-oriented response including the release of proinflammatory cytokines, chemokines, and IgE. These mechanisms are known as mediators in the pathogenesis of atopic dermatitis, food allergy, allergic rhinitis with and without polyposis, and asthma. We report the clinical case of a patient in which the Th2-mediated inflammatory substrate is evident in comorbid allergic manifestations who show a good response after treatment with Dupilumab for moderate atopic dermatitis

Keywords

dupilumab; atopic dermatits; th2 response; food allergy

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.